Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002675 stock hub

SHE/002675 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002675is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.8B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002675

In the news

Latest news · SHE/002675

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.5

P25 17.1P50 24.2P75 37.8

Trailing P/E52.7

P25 23.5P50 41.3P75 83.2

ROE3.2

P25 -0.9P50 4.1P75 8.8

ROIC5.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002675 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

CNY

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,583
Employees Change	114%
Employees Change Percent	4.62
Enterprise value	CNY 11.7B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100001DP5
Last refreshed	2026-05-10
Market cap	CNY 10.8B
Price	CNY 13.05
Price currency	CNY
Rev Per Employee	1,037,751.97x
Sector	Healthcare
Sic	2833
Symbol	she/002675
Website	https://www.dcb-group.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.9%
EV Earnings	57.48x
EV/EBIT	30.84x
EV/EBITDA	20.13x
EV/FCF	160.6x
EV/Sales	4.38x
FCF yield	0.68%
Forward P/E	27.45x
P/B ratio	1.99x
P/E ratio	52.69x
P/S ratio	4.01x
PE Ratio10 Y	59.49x
PE Ratio3 Y	67.36x
PE Ratio5 Y	62.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.21%
EBITDA Margin	21.09%
FCF margin	2.73%
Gross margin	52.46%
Gross Profit	CNY 1.4B
Gross Profit Growth	2.22%
Gross Profit Growth Q	6.86%
Gross Profit Growth3 Y	-4.23%
Gross Profit Growth5 Y	-3.5%
Net Income	CNY 204.3M
Net Income Growth	41.67%
Net Income Growth Q	35.19%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	-12.26%
Net Income Growth5 Y	-13.04%
Pretax Margin	8.39%
Profit Margin	7.62%
Profit Per Employee	CNY 79,107
Profitable Years	18
ROA	2.66
Roa5y	3.38
ROCE	4.98
ROE	3.19
Roe5y	4.46
ROIC	5.6
Roic5y	6.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.6%
Cagr1y	-11.17%
Cagr3y	-3.37%
Cagr5y	-6.24%
Div CAGR10	8.2%
Div CAGR3	-18.7%
Div CAGR5	-20.26%
EPS Growth	41.6
EPS Growth Q	35
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	-12.67
EPS Growth5 Y	-13.52
FCF Growth	-50.87%
FCF Growth3 Y	-46.1%
FCF Growth5 Y	-26.15%
OCF Growth	-23.32%
OCF Growth10 Y	15.45%
OCF Growth3 Y	-20.14%
OCF Growth5 Y	-6.8%
Revenue Growth	-7.84x
Revenue Growth Q	-8.82x
Revenue Growth Years	0x
Revenue Growth3 Y	-8.97x
Revenue Growth5 Y	-5.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.3
Assets	CNY 9.2B
Cash	CNY 992.9M
Current Assets	CNY 2.6B
Current Liabilities	CNY 1.5B
Debt	CNY 858.8M
Debt EBITDA	CNY 1.47
Debt Equity	CNY 0.16
Debt FCF	CNY 11.74
Equity	CNY 5.4B
Interest Coverage	2.6
Liabilities	CNY 3.8B
Long Term Assets	CNY 6.6B
Long Term Liabilities	CNY 2.2B
Net Cash	CNY 134.1M
Net Cash By Market Cap	CNY 1.25
Net Cash Growth	276.05%
Net Debt EBITDA	CNY -0.24
Net Debt Equity	CNY -0.02
Net Debt FCF	CNY -1.83
Tangible Book Value	CNY 1.5B
Tangible Book Value Per Share	CNY 1.85
WACC	4.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.71
Inventory Turnover	2.32
Net Working Capital	CNY 432.1M
Quick ratio	1.34
Working Capital	CNY 1.1B
Working Capital Turnover	CNY 2.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.05%
Dividend Growth	0.78%
Dividend Growth Years	0%
Dividend per share	CNY 0.08
Dividend Years	14
Dividend Yield	0.62%
Ex Div Date	2026-04-29
Last Dividend	CNY 0.08
Payout Frequency	Annual
Payout Ratio	51.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	6.17%
1Y total return	-11.17%
200-day SMA	14.75
3Y total return	-9.76%
50-day SMA	13.46
50-day SMA vs 200-day SMA	50under200
5Y total return	-27.54%
All Time High	29.6
All Time High Change	-55.91%
All Time High Date	2020-08-04
All Time Low	3.43
All Time Low Change	280.58%
All Time Low Date	2012-12-04
ATR	0.41
Beta	-0.08
Beta1y	0.14
Beta2y	0.26
Ch YTD	-5.02
High	13.25
High52	18.68
High52 Date	2025-08-14
High52ch	-30.14%
Low	12.99
Low52	12.12
Low52 Date	2026-03-23
Low52ch	7.67%
Ma50ch	-3.05%
Price vs 200-day SMA	-11.5%
RSI	40.26
RSI Monthly	44.4
RSI Weekly	42.41
Sharpe ratio	-0.35x
Sortino ratio	-0.36
Total Return	0.57%
Tr YTD	-4.45
Tr1m	-9.08%
Tr1w	0.23%
Tr3m	-3.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 380.9M
Operating Income Growth	30.71
Operating Income Growth Q	47.49
Operating Income Growth3 Y	-11.87
Operating Income Growth5 Y	-9.65
Operating margin	14.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	470,120,620%
Net Borrowing	59,183,079
Shares Insiders	21.38%
Shares Institutions	12.05%
Shares Out	824,595,705
Shares Qo Q	0.1%
Shares Yo Y	0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 73.1M
Average Volume	18,932,853.05x
Bv Per Share	5.2
CAPEX	CNY -361.3M
Ch10y	-2.25
Ch1m	-9.63
Ch1w	0.23
Ch1y	-11.88
Ch3m	-4.11
Ch3y	-12.65
Ch5y	-31.57
Ch6m	-16.08
Change	0.15%
Change From Open	0.08
Close	13.03
Days Gap	0.08
Depreciation Amortization	184,507,078
Dollar Volume	149,375,689.7
Earnings Date	2026-04-28
EBIT	CNY 380.9M
EBITDA	CNY 565.4M
EPS	CNY 0.25
F Score	6
FCF	CNY 73.1M
FCF EV Yield	0.62x
FCF Per Share	CNY 0.09
Financing CF	191,633,006
Fiscal Year End	December
Founded	1,998
Goodwill	2,484,238,678
Graham Number	5.38202
Graham Upside	-58.76
Income Tax	CNY 52.8M
Investing CF	-497,446,370
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2016-08-30
Last Split Type	Forward
Lynch Fair Value	CNY 1.24
Lynch Upside	-90.51
Ma150	14.19
Ma150ch	-8.03%
Ma20	13.71
Ma20ch	-4.81%
Net CF	120,118,796
Next Earnings Date	2026-05-15
Open	13.04
P FCF Ratio	147.1
P OCF Ratio	24.77
Payment Date	2026-04-29
Position In Range	23.08
Ppne	2,624,663,805
Price Date	2026-05-08
Price EBITDA	CNY 19.03
Ptbv Ratio	7.05
Relative Volume	0.61x
Revenue	2,680,513,349x
Tax By Revenue	1.97x
Tax Rate	23.48%
Tr6m	-15.57%
Volume	11,446,413
Z Score	2.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002675 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$0.08 annual per share

Payout ratio

+51.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-20.3%

0 consecutive years of growth

Total shareholder yield

+0.6%

Next ex-dividend date: 2026-04-29

Performance

SHE/002675 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002675?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.1%

Share of float held by funds and institutions

Insider ownership

+21.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

SHE/002675 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.3

Neutral momentum band

Price vs 200-day MA

-11.5%

50/200-day relationship not available

Beta (5Y)

-0.08

Less volatile than the market

Sharpe ratio

-0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002675

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002675 stock rating?

she/002675 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002675 analysis?

The full report lives at /stocks/she/002675/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002675?

The latest report frames she/002675 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002675 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.